Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
- Resource Type
- Article
- Source
- The Lancet; October 2022, Vol. 400 Issue: 10359 p1195-1205, 11p
- Subject
- Language
- ISSN
- 01406736; 1474547X